XML 46 R37.htm IDEA: XBRL DOCUMENT
v3.25.1

Financial instruments and risk management (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Disclosure of detailed information about financial instruments [line items] |
Financial Instruments - Classification |
| Note |  | 03/31/2025 |  | 12/31/2024
Assets |  |  |  |  |
Amortized cost |  |  |  |  |
Cash and cash equivalents | 5 |  | 9,914,505 |  |  | 9,018,818 |
Marketable securities | 6 |  |  |  |  |  |
Trade accounts receivable | 7 |  | 6,354,237 |  |  | 9,132,860 |
Other assets (1) |  |  | 540,009 |  |  | 628,275 |
|  |  | 16,808,751 |  |  | 18,779,953 |
Fair value through other comprehensive income |  |  |  |  |
Investments | 14.1 |  | 1,006,820 |  |  | 1,138,066 |
|  |  | 1,006,820 |  |  | 1,138,066 |
Fair value through profit or loss |  |  |  |  |
Derivative financial instruments | 4.5.1 |  | 4,132,330 |  |  | 3,887,100 |
Marketable securities | 6 |  | 6,918,765 |  |  | 13,363,511 |
|  |  | 11,051,095 |  |  | 17,250,611 |
|  |  | 28,866,666 |  |  | 37,168,630 |
Liabilities |  |  |  |  |
Amortized cost |  |  |  |  |
Trade accounts payable | 17 |  | 5,669,809 |  |  | 6,033,285 |
Loans, financing and debentures | 18.1 |  | 91,042,571 |  |  | 101,435,531 |
Lease liabilities | 19.2 |  | 6,851,519 |  |  | 6,972,915 |
Liabilities for assets acquisitions and subsidiaries | 23 |  | 115,424 |  |  | 120,490 |
Dividends and interests on own capital payable |  |  | 7,699 |  |  | 2,200,917 |
Other liabilities (1) |  |  | 169,366 |  |  | 143,330 |
|  |  | 103,856,388 |  |  | 116,906,468 |
Fair value through profit or loss |  |  |  |  |
Derivative financial instruments | 4.5.1 |  | 7,131,448 |  |  | 10,454,820 |
|  |  | 7,131,448 |  |  | 10,454,820 |
|  |  | 110,987,836 |  |  | 127,361,288 |
|  |  | 82,121,170 |  |  | 90,192,658 |
Financial Instruments - Fair Value |
| Yield used to discount/methodology |  | 03/31/2025 |  | 12/31/2024
Quoted in the secondary market |  |  |  |  |
In foreign currency |  |  |  |  |
Bonds | Secondary Market |  | 44,487,544 |  |  | 48,734,909 |
Estimated present value |  |  |  |  |
In foreign currency |  |  |  |  |
Export credits (“Prepayment”) | SOFR |  | 21,383,389 |  |  | 22,740,891 |
Assets Financing | SOFR |  | 395,806 |  |  | 422,115 |
IFC - International Finance Corporation | SOFR |  | 6,233,706 |  |  | 6,261,715 |
ECA - Export Credit Agency | SOFR |  | 859,549 |  |  | 864,202 |
Panda Bonds - CNH | Fixed |  | 973,163 |  |  | 951,125 |
In local currency |  |  |  |  |
BNDES – TJLP | DI 1 |  | 159,443 |  |  | 171,109 |
BNDES – TLP | DI 1 |  | 3,329,356 |  |  | 3,275,012 |
BNDES – TR | DI 1 |  | 34,070 |  |  | 33,466 |
BNDES – Selic (“Special Settlement and Custody System”) | DI 1 |  | 635,999 |  |  | 645,139 |
BNDES – UMBNDES | DI 2 |  | 104,408 |  |  | 106,966 |
Assets Financing | DI 1 |  | 58,807 |  |  | 60,566 |
Debentures | DI 1/IPCA |  | 12,127,177 |  |  | 12,002,992 |
NCE (“Export Credit Notes”) | DI 1 |  | 107,507 |  |  | 108,308 |
NCR (“Rural Credit Notes”) | DI 1 |  | 2,146,140 |  |  | 2,424,457 |
|  |  | 93,036,064 |  |  | 98,802,972 |
Financial Instrument - Liquidity risk |
|  |  |  |  |  |  |  |  |  |  | 03/31/2025
| Book value |  | Undiscounted cash flow |  | Up to 1 year |  | 1 - 2 years |  | 2 - 5 years |  | More than 5 years
Liabilities |  |  |  |  |  |  |  |  |  |  |
Trade accounts payables | 5,669,809 |  |  | 5,669,809 |  |  | 5,669,809 |  |  |  |  |  |  |
Loans, financing and debentures | 91,042,571 |  |  | 129,403,665 |  |  | 7,379,898 |  |  | 21,540,133 |  |  | 42,972,193 |  |  | 57,511,441 |
Lease liabilities | 6,851,519 |  |  | 12,320,600 |  |  | 1,633,972 |  |  | 1,167,781 |  |  | 3,068,159 |  |  | 6,450,688 |
Liabilities for asset acquisitions and subsidiaries | 115,424 |  |  | 139,098 |  |  | 21,722 |  |  | 20,772 |  |  | 96,604 |  |  |
Derivative financial instruments | 7,131,448 |  |  | 10,699,641 |  |  | 449,418 |  |  | 381,761 |  |  | 1,268,687 |  |  | 8,599,775 |
Dividends and interests on own capital payable | 7,699 |  |  | 7,699 |  |  | 7,699 |  |  |  |  |  |  |
Other liabilities | 169,366 |  |  | 169,366 |  |  | 72,488 |  |  | 96,878 |  |  |  |  |
| 110,987,836 |  |  | 158,409,878 |  |  | 15,235,006 |  |  | 23,207,325 |  |  | 47,405,643 |  |  | 72,561,904 |
|  |  |  |  |  |  |  |  |  |  | 12/31/2024
| Book value |  | Undiscounted cash flow |  | Up to 1 year |  | 1 - 2 years |  | 2 - 5 years |  | More than 5 years
Liabilities |  |  |  |  |  |  |  |  |  |  |
Trade accounts payables | 6,033,285 |  |  | 6,033,285 |  |  | 6,033,285 |  |  |  |  |  |  |
Loans, financing and debentures | 101,435,531 |  |  | 142,028,543 |  |  | 13,599,011 |  |  | 14,235,170 |  |  | 50,858,667 |  |  | 63,335,695 |
Lease liabilities | 6,972,915 |  |  | 12,099,294 |  |  | 1,302,590 |  |  | 1,176,832 |  |  | 3,094,493 |  |  | 6,525,379 |
Liabilities for asset acquisitions and subsidiaries | 120,490 |  |  | 146,082 |  |  | 23,425 |  |  | 22,400 |  |  | 100,257 |  |  |
Derivative financial instruments | 10,454,820 |  |  | 13,878,150 |  |  | 1,676,180 |  |  | 957,540 |  |  | 1,489,357 |  |  | 9,755,073 |
Dividends and interests on own capital payable | 2,200,917 |  |  | 2,200,917 |  |  | 2,200,917 |  |  |  |  |  |  |
Other liabilities | 143,330 |  |  | 143,330 |  |  | 60,892 |  |  | 82,438 |  |  |  |  |
| 127,361,288 |  |  | 176,529,601 |  |  | 24,896,300 |  |  | 16,474,380 |  |  | 55,542,774 |  |  | 79,616,147 |
Financial Instruments - Exchange rate risk management |
| 03/31/2025 |  | 12/31/2024
Assets |  |  |
Cash and cash equivalents | 8,157,219 |  |  | 6,496,039 |
Marketable securities | 49,870 |  |  | 70,255 |
Trade accounts receivable | 4,539,485 |  |  | 7,090,160 |
Derivative financial instruments | 2,894,453 |  |  | 3,887,100 |
| 15,641,027 |  |  | 17,543,554 |
Liabilities |  |  |
Trade accounts payable | (1,527,479) |  |  | (1,350,763) |
Loans and financing | (72,660,737) |  |  | (83,004,915) |
Liabilities for asset acquisitions and subsidiaries | (87,698) |  |  | (93,308) |
Derivative financial instruments | (5,374,754) |  |  | (10,448,379) |
| (79,650,668) |  |  | (94,897,365) |
| (64,009,641) |  |  | (77,353,811) |
Financial Instruments - sensitivity analysis |
| 03/31/2025
| Effect on profit or loss
| Probable (base value) |  | Possible (25%) |  | Remote (50%)
Cash and cash equivalents | 8,157,219 |  |  | 2,039,305 |  |  | 4,078,610 |
Marketable securities | 49,870 |  |  | 12,468 |  |  | 24,935 |
Trade accounts receivable | 4,539,485 |  |  | 1,134,871 |  |  | 2,269,743 |
Trade accounts payable | (1,527,479) |  |  | (381,870) |  |  | (763,740) |
Loans and financing | (72,660,737) |  |  | (18,165,184) |  |  | (36,330,369) |
Liabilities for asset acquisitions and subsidiaries | (87,698) |  |  | (21,925) |  |  | (43,849) |
| 03/31/2025
| Effect on profit or loss
| Probable (base value) |  | Possible (25%) |  | Remote (50%)
Embedded derivative in a commitment to purchase standing wood, originating from a forest partnership agreement | (23,225) |  |  | (31,031) |  |  | (63,614) |
Financial Instruments - Sensitivity analysis foreign exchange - derivative |
| 03/31/2025
| Effect on profit or loss
| Probable (base value) |  | Possible 25% |  | Remote 50%
Dollar/Real |  |  |  |  |
Derivative financial instruments |  |  |  |  |
Derivative options | (1,518,526) |  |  | (8,199,971) |  |  | (17,829,451) |
Derivative swaps | (1,449,747) |  |  | (2,500,027) |  |  | (4,807,341) |
Derivative Non-Deliverable Forward (‘NDF’) Contracts | (36,977) |  |  | (255,861) |  |  | (511,664) |
Embedded derivatives | (23,225) |  |  | (178,519) |  |  | (357,039) |
Commodity Derivatives | 29,357 |  |  | 7,337 |  |  | 14,676 |
|  | Notional value, net in U.S.$ |  | Fair value in R$
|  | 03/31/2025 |  | 12/31/2024 |  | 03/31/2025 |  | 12/31/2024
Instruments as part of cash flow protection strategy |  |  |  |  |  |  |  |
Cash flow hedge |  |  |  |  |  |  |  |
Zero Cost Collar |  | 7,264,700 |  |  | 6,852,200 |  |  | (1,518,526) |  |  | (4,328,970) |
NDF (R$ x US$) |  | 185,000 |  |  | 581,000 |  |  | (36,977) |  |  | (331,876) |
Debt hedges |  |  |  |  |  |  |  |
Swap SOFR x Fixed (US$) |  | 1,687,593 |  |  | 1,973,705 |  |  | 244,452 |  |  | 394,129 |
Swap IPCA x CDI (notional in Brazilian Reais) |  | 8,053,063 |  |  | 8,128,395 |  |  | (764,449) |  |  | (825,899) |
Swap CNH x Fixed (US$) |  | 165,815 |  |  | 165,815 |  |  | (7,456) |  |  | (6,440) |
Swap CDI x Fixed (US$) |  | 903,827 |  |  | 909,612 |  |  | (570,496) |  |  | (776,261) |
Swap CDI x SOFR (US$) |  | 610,171 |  |  | 610,171 |  |  | (331,078) |  |  | (590,764) |
Swap SOFR x SOFR (US$) |  | 150,961 |  |  | 150,961 |  |  | (20,720) |  |  | (37,850) |
Commodity Hedge |  |  |  |  |  |  |  |
Swap US$ e US-CPI (1) |  | 138,182 |  |  | 138,439 |  |  | (23,226) |  |  | (80,759) |
Zero Cost Collar (Brent) |  | 209,530 |  |  | 163,941 |  |  | 25,512 |  |  | 6,097 |
Swap VLSFO/Brent |  | 23,027 |  |  | 39,706 |  |  | 3,846 |  |  | 10,873 |
|  |  |  |  |  | (2,999,118) |  |  | (6,567,720) |
Current assets |  |  |  |  |  | 888,004 |  |  | 1,006,427 |
Non-current assets |  |  |  |  |  | 3,244,326 |  |  | 2,880,673 |
Current liabilities |  |  |  |  |  | (1,561,094) |  |  | (2,760,273) |
Non-current liabilities |  |  |  |  |  | (5,570,354) |  |  | (7,694,547) |
|  |  |  |  |  | (2,999,118) |  |  | (6,567,720) |
Financial Instruments - Fair Value Maturity |
| 03/31/2025 |  | 12/31/2024
2025 | (292,400) |  |  | (1,753,846) |
2026 | (505,985) |  |  | (1,699,768) |
2027 | 247,451 |  |  | (36,905) |
2028 onwards | (2,448,184) |  |  | (3,077,201) |
| (2,999,118) |  |  | (6,567,720) |
Financial Instruments - Outstanding assets and liabilities |
|  |  |  | Notional value |  | Fair value in R$
|  | Currency |  | 03/31/2025 |  | 12/31/2024 |  | 03/31/2025 |  | 12/31/2024
Debt hedges |  |  |  |  |  |  |  |  |  |
Assets |  |  |  |  |  |  |  |  |  |
Swap CDI to Fixed |  | US$ |  | 4,650,715 |  |  | 4,748,394 |  |  | 1,441,090 |  |  | 1,482,759 |
Swap SOFR to Fixed |  | US$ |  | 1,687,593 |  |  | 1,973,705 |  |  | 250,548 |  |  | 424,824 |
Swap IPCA to CDI |  | R$ |  | 8,456,042 |  |  | 8,382,699 |  |  | 900,125 |  |  | 927,586 |
Swap CDI to SOFR |  | US$ |  | 3,117,625 |  |  | 3,117,625 |  |  | 874,462 |  |  | 754,173 |
Swap CNH to Fixed |  | CNH |  | 1,200,000 |  |  | 1,200,000 |  |  | 25,935 |  |  |  |
Swap SOFR to SOFR |  | US$ |  | 150,961 |  |  | 150,961 |  |  | 5,366 |  |  | 4,949 |
|  |  |  |  |  |  |  | 3,497,526 |  |  | 3,594,291 |
Liabilities |  |  |  |  |  |  |  |  |  |
Swap CDI to Fixed |  | US$ |  | 903,827 |  |  | 909,612 |  |  | (2,011,586) |  |  | (2,259,020) |
Swap SOFR to Fixed |  | US$ |  | 1,687,593 |  |  | 1,973,705 |  |  | (6,096) |  |  | (30,695) |
Swap IPCA to CDI |  | R$ |  | 8,053,063 |  |  | 8,128,395 |  |  | (1,664,574) |  |  | (1,753,485) |
Swap CDI to SOFR |  | US$ |  | 610,171 |  |  | 610,171 |  |  | (1,205,540) |  |  | (1,344,937) |
Swap CNH to Fixed |  | CNH |  | 165,815 |  |  | 165,815 |  |  | (33,391) |  |  | (6,440) |
Swap SOFR to SOFR |  | US$ |  | 150,961 |  |  | 150,961 |  |  | (26,086) |  |  | (42,799) |
|  |  |  |  |  |  |  | (4,947,273) |  |  | (5,437,376) |
|  |  |  |  |  |  |  | (1,449,747) |  |  | (1,843,085) |
Cash flow hedge |  |  |  |  |  |  |  |  |  |
Zero Cost Collar (US$ x R$) |  | US$ |  | 7,264,700 |  |  | 6,852,200 |  |  | (1,518,526) |  |  | (4,328,970) |
NDF (R$ x US$) |  | US$ |  | 185,000 |  |  | 581,000 |  |  | (36,977) |  |  | (331,876) |
|  |  |  |  |  |  |  | (1,555,503) |  |  | (4,660,846) |
Commodity hedge |  |  |  |  |  |  |  |  |  |
Swap US-CPI (standing wood) (1) |  | US$ |  | 138,182 |  |  | 138,439 |  |  | (23,226) |  |  | (80,759) |
Zero Cost Collar (Brent) |  | US$ |  | 209,530 |  |  | 163,941 |  |  | 25,512 |  |  | 6,097 |
Swap VLSFO/Brent |  | US$ |  | 23,027 |  |  | 39,706 |  |  | 3,846 |  |  | 10,873 |
|  |  |  |  |  |  |  | 6,132 |  |  | (63,789) |
|  |  |  |  |  |  |  | (2,999,118) |  |  | (6,567,720) |
Financial Instruments - Fair Value Settled |
| 03/31/2025 |  | 12/31/2024
Cash flow hedge |  |  |
Zero Cost Collar (R$ x US$) | 1,475 |  |  | 645,759 |
NDF (R$ x US$) | (30,142) |  |  | (68,695) |
NDF (€ x US$) |  |  | 73,781 |
| (28,667) |  |  | 650,845 |
Commodity Hedge | 8,733 |  |  | 89,327 |
Swap VLSFO/other | 8,733 |  |  | 89,327 |
Debt hedges |  |  |
Swap CDI to Fixed (US$) | 90,068 |  |  | (1,635,058) |
Swap IPCA to CDI (Brazilian Reais) | (43,312) |  |  | (59,243) |
Swap Pre-Fixed to US$ |  |  |  | (221,462) |
Swap SOFR to SOFR (US$) | 1,504 |  |  | 2,199 |
Swap CDI to SOFR (US$) | 21,482 |  |  | 19,074 |
Swap SOFR to Fixed (US$) | 74,750 |  |  | 603,737 |
| 144,492 |  |  | (1,290,753) |
| 124,558 |  |  | (550,581) |
Financial Instruments - Fair Value Hierarchy |
|  |  |  |  |  | 03/31/2025
|  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |  |
At fair value through profit or loss |  |  |  |  |  |  |  |
Derivative financial instruments |  |  |  | 4,132,330 |  |  |  |  | 4,132,330 |
Marketable securities |  | 1,227,033 |  |  | 5,691,732 |  |  |  |  | 6,918,765 |
|  | 1,227,033 |  |  | 9,824,062 |  |  |  |  |  | 11,051,095 |
At fair value through other comprehensive income |  |  |  |  |  |  |  |
Other investments (note 14.1) |  | 971,384 |  |  |  |  | 35,436 |  |  | 1,006,820 |
|  | 971,384 |  |  |  |  |  | 35,436 |  |  | 1,006,820 |
Biological assets |  |  |  |  |  | 22,861,555 |  |  | 22,861,555 |
|  |  |  |  |  |  |  | 22,861,555 |  |  | 22,861,555 |
Total assets |  | 2,198,417 |  |  | 9,824,062 |  |  | 22,896,991 |  |  | 34,919,470 |
Liabilities |  |  |  |  |  |  |  |
At fair value through profit or loss |  |  |  |  |  |  |  |
Derivative financial instruments |  |  |  | 7,131,448 |  |  |  |  | 7,131,448 |
|  |  |  |  | 7,131,448 |  |  |  |  |  | 7,131,448 |
|  |  |  |  | 7,131,448 |  |  |  |  |  | 7,131,448 |
|  |  |  |  |  |  | 12/31/2024
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |
At fair value through profit or loss |  |  |  |  |  |  |
Derivative financial instruments |  |  | 3,887,100 |  |  |  |  | 3,887,100 |
Marketable securities | 1,203,776 |  |  | 12,159,735 |  |  |  |  | 13,363,511 |
| 1,203,776 |  |  | 16,046,835 |  |  |  |  |  | 17,250,611 |
At fair value through other comprehensive income |  |  |  |  |  |  |
Other investments - (note 14.1) |  |  |  |  | 38,196 |  |  | 1,138,066 |
| 1,099,870 |  |  |  |  |  | 38,196 |  |  | 1,138,066 |
Biological assets |  |  |  |  | 22,283,001 |  |  | 22,283,001 |
|  |  |  |  |  |  | 22,283,001 |  |  | 22,283,001 |
Total assets | 2,303,646 |  |  | 16,046,835 |  |  | 22,321,197 |  |  | 40,671,678 |
Liabilities |  |  |  |  |  |  |
At fair value through profit or loss |  |  |  |  |  |  |
Derivative financial instruments |  |  | 10,454,820 |  |  |  |  | 10,454,820 |
|  |  |  | 10,454,820 |  |  |  |  |  | 10,454,820 |
Total liabilities |  |  |  | 10,454,820 |  |  |  |  |  | 10,454,820 |
Interest rate risk [member] | Financial instruments, excluding derivatives |
Disclosure of detailed information about financial instruments [line items] |
Financial Instruments - sensitivity analysis |
| 03/31/2025
| Effect on profit or loss
| Probable |  | Possible (25%) |  | Remote (50%)
CDI/SELIC |  |  |  |  |
Cash and cash equivalents | 1,595,620 |  |  | 56,445 |  |  | 112,890 |
Marketable securities | 5,618,783 |  |  | 198,764 |  |  | 397,529 |
Loans and financing | 9,121,748 |  |  | 322,682 |  |  | 645,364 |
TJLP/TLP |  |  |  |  |
Loans and financing | 176,317 |  |  | 3,513 |  |  | 7,026 |
SOFR |  |  |  |  |
Loans and financing | 24,742,476 |  |  | 272,786 |  |  | 545,572 |
Interest rate risk [member] | Derivative financial instruments |
Disclosure of detailed information about financial instruments [line items] |
Financial Instruments - sensitivity analysis |
| 03/31/2025
| Effect on profit or loss
| Probable |  | Probable 25% |  | Remote 50%
CDI |  |  |  |  |
Derivative financial instruments |  |  |  |  |
Liabilities |  |  |  |  |
Derivative options | (1,518,526) |  |  | (710,263) |  |  | (1,419,548) |
Derivative swaps | (1,449,747) |  |  | (89,057) |  |  | (174,810) |
SOFR |  |  |  |  |
Derivative financial instruments |  |  |  |  |
Liabilities |  |  |  |  |
Derivative swaps | (1,449,747) |  |  | (133,048) |  |  | (257,526) |

X
- Definition The disclosure of derivative financial instruments. [Refer: Derivatives [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 10 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_10_e&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of detailed information about financial instruments. [Refer: Classes of financial instruments [domain]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 31 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_31&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 7 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_7&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35K -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35K&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the effect of changes in foreign exchange rates. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 21 -IssueDate 2024-01-01 -Section Disclosure -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS21_g51-57_TI -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for fair value measurement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2024-01-01 -Section Disclosure -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS13_g91-99_TI -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfFairValueMeasurementExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfFinancialInstrumentsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of liquidity risk. [Refer: Liquidity risk [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 10 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_10_e&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfLiquidityRiskExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the sensitivity analysis for types of market risk to which the entity is exposed, showing how profit or loss and equity would have been affected by changes in the relevant risk variable that were reasonably possible at that date. [Refer: Market risk [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 40 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_40_a&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of Fair Value Hierarchy + References No definition available. + Details
Name: | suz_DisclosureOfFairValueHierarchyTableTextBlock
Namespace Prefix: | suz_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of Positions of Derivative Financial Instruments + References No definition available. + Details
Name: | suz_DisclosureOfPositionsOfDerivativeFinancialInstrumentsTableTextBlock
Namespace Prefix: | suz_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of Settled Derivatives + References No definition available. + Details
Name: | suz_DisclosureOfSettledDerivativesTableTextBlock
Namespace Prefix: | suz_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of fair value by maturity + References No definition available. + Details
Name: | suz_ScheduleOfFairValueByMaturityTableTextBlock
Namespace Prefix: | suz_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=suz_FinancialInstrumentsExcludingDerivativesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_DerivativesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |